have shown previously that the mutated class I MHC molecules abrogate acute and chronic rejection and attenuate transplant vascular sclerosis (TVS) through the early changes (1-7 days post-transplantation ... cell…
Chronic rejection in organ transplantation is a complex process driven by immunologic and non-immunologic factors. Alloantibodies and T-cell responses mediate immune-driven damage, while ischemia-reperfusion injury
have shown previously that the mutated class I MHC molecules abrogate acute and chronic rejection and attenuate transplant vascular sclerosis (TVS) through the early changes (1-7 days post-transplantation ... cell…
cells, dendritic cells and natural killer cells as well as increasing vascularisation. Chronic graft rejection is now the leading cause of graft dysfunction and failure. Long term anti-rejection therapy ... feel well…
Background: Chronic rejection (CR) is the dominant cause of kidney transplant failure, and is characterized by vasculopathy, glomerulopathy, tubular atrophy and interstitial fibrosis. To date, there is no effective…
Chronic rejection remains a major challenge in organ transplantation, characterized by progressive graft fibrosis and dysfunc tion. This complex process involves immune-mediated mechanisms, including donor-specific…
decade mainly by the new potent immunosuppressants. Main causes of graft loss are chronic humoral rejection (CHR), calcineurin inhibitor (CNI) nephrotoxicity (CNINT), de novo or recurrent glomerulonephritis
recipient that identify human leukocyte antigens in the transplanted tissue or organ. In addition, chronic rejection typically develops months or years after an organ or tissue donation. The immunopathogenesis…
human leukocyte antigen (HLA) genes, non-HLA genes, and their impact on acute and chronic rejection. We discuss the implications of these findings for personalized immunosuppression and improved transplant outcomes
limited by drug-associated toxicity and the occurrence of antibody-mediated rejection or chronic rejection. The development of immunosuppressants that have minimal adverse and nephrotoxic effects is important to improve…
term graft survival due to progress in controlling acute rejections, improvement in the immunosuppression, chronic rejection remains a considerable hindrance, preventing the goal of long term graft survival. Chronic…
Chronic liver rejection poses a complex challenge in transplantation, as some patients do not respond to increased immunosuppression. Killer cell immunoglobulin-like receptors and their interactions with Class I Human
Microvascular loss may be a root cause for chronic rejection in all solid organ transplants, which leads to the bronchiolitis obliterans syndrome (BOS), a fibrotic remodeling resulting in progressive narrowing…
Chronic antibody mediated rejection (CAMR) is the main cause for late kidney transplant loss, and the results of its treatment are dissatisfying. In our one center study we evaluated ... intravenous immunoglobulin and…
patients with end-stage renal disease, but immune injury from acute or chronic allograft rejection and non-immune causes, such as nephrotoxicity from calcineurin inhibitors, ischaemia- reperfusion injury, recurrent…
expression was found in 34% cases of acute rejection and in 58% cases of chronic rejection (64% in chronic transplant glomerulopathy and 52% in transplant vasculopathy). 5-year graft survival ... forms was worse…
small bowel, detailing challenges in diagnosing conditions like antibody mediated rejection, early graft dysfunction, chronic rejection, and viral infections. The emergence of non-invasive biomarkers and the integration…
serum creatine test lacks the ability to predict future events such as acute and chronic rejection. Essentially, transplant nephroogists are force to practice reactive medcine rather than procactice medicine. There…
risks. Aspects such as renal function, infections, graft vasculopathy, the risk for malignancy and chronic rejection after HTxi remain to be examined closely